Nipro Diagnostics received FDA approval for two of its self-monitoring blood glucose systems. The monitoring systems will be available through retail, mail and distribution channels beginning in the fourth quarter under partner brands or under Nipro Diagnostics’ own TRUE brand, the company said.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.